GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » EV-to-Revenue

Baskhanbiopharma (XKRX:354390) EV-to-Revenue : 1.42 (As of Jun. 15, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Baskhanbiopharma EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Baskhanbiopharma's enterprise value is ₩43,123 Mil. Baskhanbiopharma's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩30,423 Mil. Therefore, Baskhanbiopharma's EV-to-Revenue for today is 1.42.

The historical rank and industry rank for Baskhanbiopharma's EV-to-Revenue or its related term are showing as below:

XKRX:354390' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.31   Med: 1.62   Max: 2.32
Current: 1.41

During the past 4 years, the highest EV-to-Revenue of Baskhanbiopharma was 2.32. The lowest was 1.31. And the median was 1.62.

XKRX:354390's EV-to-Revenue is ranked better than
67.98% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 2.24 vs XKRX:354390: 1.41

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-15), Baskhanbiopharma's stock price is ₩6390.00. Baskhanbiopharma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩4,336.25. Therefore, Baskhanbiopharma's PS Ratio for today is 1.47.


Baskhanbiopharma EV-to-Revenue Historical Data

The historical data trend for Baskhanbiopharma's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baskhanbiopharma EV-to-Revenue Chart

Baskhanbiopharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
- - 1.48 1.51

Baskhanbiopharma Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
EV-to-Revenue - - 1.48 1.51

Competitive Comparison of Baskhanbiopharma's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Baskhanbiopharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baskhanbiopharma's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Baskhanbiopharma's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Baskhanbiopharma's EV-to-Revenue falls into.



Baskhanbiopharma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Baskhanbiopharma's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=43123.482/30423.119
=1.42

Baskhanbiopharma's current Enterprise Value is ₩43,123 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Baskhanbiopharma's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩30,423 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baskhanbiopharma  (XKRX:354390) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Baskhanbiopharma's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=6390.00/4336.248
=1.47

Baskhanbiopharma's share price for today is ₩6390.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was ₩4,336.25.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baskhanbiopharma EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Baskhanbiopharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Baskhanbiopharma (XKRX:354390) Business Description

Traded in Other Exchanges
N/A
Address
354 Wondang-ro, Wongok-myeon, Anseong-si, Gyeonggi-do, KOR
Baskhanbiopharma Inc manufactures and distributes prescription drugs, over the counter drugs, medical devices and other related products.

Baskhanbiopharma (XKRX:354390) Headlines

No Headlines